Magic mushroom compound probes brain in FND patients
NCT ID NCT05723276
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study looks at how a single dose of psilocybin, the active ingredient in magic mushrooms, affects brain networks in 24 adults with functional neurological disorder (FND). Participants receive the drug with therapeutic support, and brain scans are taken before and after to see if a key network called the default mode network changes. The goal is to understand brain function in FND, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL NEUROLOGICAL DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
South London and Maudsley NHS Foundation Trust
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Training the heart to calm the brain: a new hope for functional neurological disorders?
- Could a gentle ear zap boost physiotherapy for a mysterious brain disorder?
- Talking therapy may ease symptoms of functional movement disorder
- New study aims to map out best treatments for FND
- Can a phone app retrain your tremor?
- Could a clear diagnosis talk change how patients feel about their condition?